Kester Capital, a lower mid-market private equity specialist, completed the investment in MAP Patient Access, a company in market access consulting services to the pharmaceutical and biotech sectors. Financial terms were not disclosed. “Kester has been targeting the market access and reimbursement sector for some time and we are delighted to have the opportunity to invest in MAP, one of the leading businesses in this space. We are looking forward to partnering with Dan, Christian and the existing management team to continue the growth of the business organically and through acquisition,” Adam Maidment, Kester Capital Managing Partner.